A third dose of Pfizer’s vaccine significantly improved protection against infection and severe cases of Covid-19 among people aged 60 and over. IsraelCompared to those who received two doses, the results of a study published by the country’s Ministry of Health showed on Sunday (22).
The data was presented at a ministerial committee meeting of vaccination experts on Thursday (19) and appeared on the ministry’s website on Sunday (22), although full details of the study were not disclosed.
Israeli Prime Minister Naftali Bennett receives the third dose of the vaccine from Pfizer as part of a reinforced campaign to limit the spread of the Delta type across the country
The results were similar to statistics released last week by the Israeli health group Maccabi, one of several organizations administering booster doses to try to contain the delta type of coronavirus.
Ministry officials said the detailed statistics are from Israel’s eKI Institute Among subjects over 60 years of age, protection against infection offered ten days after the third dose was four times greater than the dose after the two doses.
A third dose for over 60s has given five to six times more protection after ten days of serious illness and hospitalization.
This age group is particularly vulnerable to Covid-19, and in Israel they were the first to receive vaccinations in late December.
In recent weeks, the Department of Health said immunity has declined over time for the elderly and young alike.
Most of the seriously ill vaccinated people in Israel are over the age of 60.
Israel began giving the third dose in over 60 years on July 30. On Thursday, it lowered the age of eligibility to more than 40, and it included pregnant women, teachers and underage health workers.
“Devoted food specialist. General alcohol fanatic. Amateur explorer. Infuriatingly humble social media scholar. Analyst.”